Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In vivo administration of nonlethal doses of
lipopolysaccharide
(
LPS
) to rodents can result in protection from subsequent lethal doses of endotoxin or
LPS
. We have previously demonstrated that hepatic
ischemia
/reperfusion (I/R) results in a TNF-dependent lung and liver injury and we postulated that pretreatment with sublethal concentrations of
LPS
prior to hepatic I/R could be protective from this injury. To test this hypothesis, five groups of rats were studied.
LPS
-I/R received 25 micrograms of
LPS
i.v. 24 hr prior to I/R, VEH-I/R received an equivalent volume of vehicle iv 24 hr prior to I/R,
LPS
-
LPS
received 25 micrograms of
LPS
i.v. 24 hr prior to sham laparotomy at which time an additional 25 micrograms of
LPS
was given i.v., VEH-
LPS
received an equivalent volume of vehicle 24 hr prior to sham laparotomy and 25 micrograms of
LPS
i.v. immediately prior to sham laparotomy, and SHAM consisted of sham-operated control animals. Peak plasma tumor necrosis factor-alpha (TNF) levels occurred between 30 and 150 min of reperfusion:
LPS
-I/R = 778 +/- 150 pg/ml (n = 5), VEH-I/R = 145 +/- 46 pg/ml (n = 5),
LPS
-
LPS
= 970 +/- 716 pg/ml (n = 4), VEH-
LPS
= 15,949 +/- 10,937 (n = 5), and SHAM = 3 +/- 1 (n = 5). As previously demonstrated by other investigators, pretreatment with
LPS
decreases TNF release in response to a second dose of
LPS
; however, TNF release was increased following hepatic I/R in those animals pretreated with
LPS
(
LPS
-I/R vs VEH-I/R, P = 0.014).(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:LPS pretreatment protects from hepatic ischemia/reperfusion. 807 80
The objective of this study was to investigate the effect of hypoxia on the adhesiveness of endothelial cells for granulocytes. Human umbilical vein endothelial cells (HUVEC) were exposed to a PO2 of 7.5 mmHg (1.0 kPa), and the adherence of granulocytes was assessed under continuous hypoxia by means of a hypoxic incubator room. After 2 h of hypoxia the adherence of granulocytes decreased to 50% of the normoxic control, which was not due to a decreased viability of the endothelial cells nor to an increased generation of the antiadhesive factors nitric oxide, prostacyclin, and adenosine. Hypoxia also had no effect on the expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 on the endothelium. Although the mechanism of the action of hypoxia on the adhesiveness of endothelial cells remains unclear as yet, our data suggest that HUVEC possess a protective mechanism that prevents granulocyte adherence to endothelial cells under extreme hypoxic conditions. The decreased adherence seems paradoxical to the in vivo situation for which the increased margination of granulocytes within the vascular compartment of the ischemic tissue has been observed. However, hypoxia did not impair the potential adhesiveness of HUVEC, since stimulation of endothelial cells under hypoxic conditions with calcium ionophore or
lipopolysaccharide
increased the adherence of granulocytes in a similar fashion as under normoxic conditions. We therefore conclude that the increased margination of granulocytes during
ischemia
may be accomplished by the additional stimulation of hypoxic endothelial cells.
...
PMID:Effect of hypoxia on adherence of granulocytes to endothelial cells in vitro. 809 91
Mechanisms of Mn-superoxide dismutase (Mn-SOD) expression in human umbilical endothelial cells were investigated by Northern blot analysis, enzyme-linked immunosorbent assay, and immunoelectron microscopy. The Mn-SOD in human endothelial cells was markedly induced by the cytokines tumor necrosis factor (TNF), interleukin-1, and
lipopolysaccharide
as well as by phorbol esters [12-O-tetradecanoylphorbol 13-acetate (TPA)]. The induction was partially blocked by dexamethasone and 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a potent inhibitor of protein kinase C (PKC). In endothelial cells in which PKC had been desensitized to TPA by pretreatment for 24 h, addition of TNF caused overexpression of Mn-SOD. These facts suggested that at least two separate signal-transducing pathways are involved in expression of the Mn-SOD gene. Immunoelectron-microscopic studies showed that Mn-SOD was localized to the mitochondrial matrix of the capillary vascular endothelial cells of cardiac tissues and cultured endothelial cells. Mn-SOD, which is normally abundant in endothelial cells relative to other cell types, may play an important protective role against stresses such as
ischemia
and inflammation.
...
PMID:Manganese-superoxide dismutase in endothelial cells: localization and mechanism of induction. 823 2
The activation and proliferation of a prostaglandin E2 (PGE2) producing monocyte/macrophage may play a major role in down-regulating immune function after injury. But the mechanism by which monocyte or macrophage activation occurs in injury is unknown. Endothelin is a 21-amino acid peptide produced by vascular endothelium in response to
ischemia
, injury, or endotoxin. Prior work from our laboratory has shown that endothelin increases intracellular calcium in monocytes and causes production of interleukins-6 and -8. In the data reported in this paper, 10(-9) M endothelin stimulated human monocytes to produce 1050 +/- 63 pg/ml of PGE2 at 6 hr and 1328 +/- 47 pg/ml at 24 hr. This was nearly as much PGE2 production as that by bacterial
lipopolysaccharide
(endotoxin) stimulation (1295 +/- 47 pg/ml at 6 hr and 1506 +/- 94 at 24 hr). Endothelin had no effect on production of leukotriene B4. Endothelin may play an important initiating role in post-traumatic immunosuppression.
...
PMID:Endothelin-stimulated human monocytes produce prostaglandin E2 but not leukotriene B4. 839 50
BALB/c mice (
ischemia
: 31; controls: 15) were studied to investigate the effects of intestinal
ischemia
on antibody synthesis to peptidoglycan polysaccharide (PGPS), a ubiquitous bacterial antigen found in both gram-positive and gram-negative bacteria. The gut
ischemia
model was produced by placing a vessel loop around the superior mesenteric vessels for 45 minutes. All animals in the
ischemia
group had visible gut
ischemia
. Eighteen animals (58%) in the
ischemia
group survived to 24 hours and all experienced total recovery of gut viability. Single-cell suspensions of splenic lymphocytes were made. After 5 days of culture with
lipopolysaccharide
, anti-PGPS immunoglobulin concentrations in culture supernatants were measured by ELISA using high-titer BALB/c anti-PGPS serum as control. The synthesis of immunoglobulin by 10(5) lymphocytes was significantly increased in the
ischemia
group compared with the controls. These results represent the translocation of bacteria after intestinal
ischemia
, and this antibody response may be important in resistance to sepsis and multiple organ dysfunction attributed to bacterial translocation.
...
PMID:Antibody synthesis to peptidoglycan polysaccharide after ischemic injury of the intestine. 841 Dec 85
During the last decade intensive work on the relationships between the liver and the arachidonic acid cascade has greatly expanded our knowledge of this area of research. The liver has emerged as the major organ participating in the degradation and elimination of arachidonate products of systemic origin. The synthesis in the liver of arachidonate products derived from the cyclooxygenase, lipoxygenase and cytochrome P450 system pathways has been demonstrated. The participation of leukotriene B4 and cysteinyl-leukotrienes as mediators of liver damage and the possible therapeutic usefulness of prostaglandins (PGs) in acute liver injury has attracted the interest of clinicians. This article reviews the essential features regarding the role of arachidonate metabolites in liver disease and specially focuses on the cytoprotective effects on the liver displayed by PGE2, PGE1, PGI2 and synthetic PG analogs in experimental models of liver damage induced by
ischemia
-reperfusion injury, carbon tetrachloride, bacterial
lipopolysaccharide
and viral hepatitis and on the possible mechanisms underlying liver cytoprotection in these experimental models. The therapeutic usefulness of PGs in clinical practice is critically analyzed on the basis of available evidence in patients with fulminant hepatic failure and primary graft nonfunction following liver transplantation.
...
PMID:Liver cytoprotection by prostaglandins. 841 74
Endotoxemia occurs when intestinal
ischemia
allows bacterial
lipopolysaccharide
to translocate from colonic flora into the bloodstream, which triggers release of cytokines that can cause hypotension, rigors, fever, shock, and even death. Recently, blood endotoxin levels were shown to be higher in athletes needing medical attention (330 pg.ml-1) than in their competitors with similar performances (81 pg.ml-1). Though there were no data showing that these athletes had elevated core temperatures or severe illness, speculation followed that endotoxin may play a causal role in heat stroke. We examined the relationship between endotoxemia and mild post-exertional illness in 39 cyclists after a 100-mile ride. Thirteen cyclists had at least one of the following: orthostatic hypotension, rigors, nausea, vomiting, diarrhea, or syncope. Only 2/26 case-controls had any of these symptoms. Data were collected on vital signs, hemoglobin, sodium, creatine kinase, creatinine, and uric acid. Endotoxin titer was determined by chromogenic assay; tumor necrosis factor alpha (TNF-alpha) titer was determined by ELISA. One ill cyclist had an endotoxin level of 330 pg.ml-1, one control had an endotoxin level of 150 pg.ml-1, but endotoxin level was < or = 64 pg.ml-1 in all others. Comparison of pre- and post-ride data showed that controls increased creatine kinase activity (154 +/- 34 vs 561 +/- 191 IU.dl, P < 0.05), creatinine concentration (1.5 +/- 0.0 vs 1.6 +/- 0.0 mg.dl-1, P < 0.05), and uric acid concentration (5.4 +/- 0.3 vs 6.3 +/- 0.3 mg.dl-1, P < 0.05). Ill cyclists had lower serum sodium than post-ride controls (138 +/- 2 vs 142 +/- 0.6 mEq.l-1, P < 0.05), but there were no differences between groups in CK, creatinine, or uric acid. These findings suggest that endotoxemia may complicate, but does not cause mild post-exertional illness in cyclists.
...
PMID:Exercise-associated collapse in cyclists is unrelated to endotoxemia. 853 21
The purpose of this study was to determine whether short-term exposure of resistance arterioles to
lipopolysaccharide
in situ is associated with changes in vasomotor tone. Using intravital microscopy, we found that suffusion of Escherichia coli
lipopolysaccharide
(3 micrograms/ml) over hamster cheek pouch arterioles for 1 h was associated with a significant immediate biphasic response: vasoconstriction followed by vasodilation (p < 0.05). The former was attenuated by indomethacin, and the latter by SK&F 108566, a selective, non-peptide angiotension II receptor antagonist (p < 0.05). The nitric oxide synthase inhibitor, NG-L-nitro arginine, had no significant effects on
lipopolysaccharide
-induced responses. Allopurinol, a scavenger of reactive oxygen species, significantly attenuated
lipopolysaccharide
-induced vasodilation. Acetylcholine- and nitroglycerin-induced vasodilation were significantly potentiated after
lipopolysaccharide
. These responses were recorded in the absence of any significant changes in systemic arterial blood pressure. Collectively, these data suggest that short-term exposure of the peripheral microcirculation to
lipopolysaccharide
in situ is associated with an
ischemia
-reperfusion-like injury. These changes may contribute to end organ failure observed several hours after exposure to
lipopolysaccharide
.
...
PMID:Short-term exposure to lipopolysaccharide is associated with microvascular contractile dysfunction in vivo. 861 41
The etiology of chronic rejection is unknown, although acute rejection, viral infection, and initial graft
ischemia
have been implicated. To test the effects of infections on the process of chronic rejection, we simulated bacterial infection by the administration of the endotoxin
lipopolysaccharide
(
LPS
), a potent activator of various cell types in an established rat model of chronic rejection. Lewis recipients of Fisher 344 kidneys were treated with a single dose of
LPS
or vehicle 8 weeks following transplantation and grafts were examined at various time points. In the chronically rejecting controls, leukocytic infiltration and the expression of cytokines peaked at 16 weeks. In
LPS
-treated hosts, leukocyte infiltration and cytokine expression peaked at 12 weeks. By 16 weeks, glomeruli in
LPS
-treated recipients had become far more sclerotic than those in controls, mimicking the changes observed in controls at 24 weeks. We conclude that infections may play an important role in the development of chronic rejection.
...
PMID:Infection-associated cellular activation accelerates chronic renal allograft rejection in rats. 863 55
Intestinal mucosal hypoperfusion with subsequent
ischemia
during endotoxemia might cause a breakdown of the gut barrier with translocation of bacteria and their toxins into the systemic circulation, thus maintaining a "gut-derived" septic state. The aim of this study was to investigate the influence of endotoxin on the microcirculation of intestinal villi, which represent the most vulnerable part of the mucosa. The changes in blood flow and in the diameters of the central villus arterioles located in the distal ileum were monitored in control rats without
lipopolysaccharide
(
LPS
) exposure (n=7), and in rats receiving 1.5 mg/kg b.w.
LPS
(n=7) or 15 mg/kg b.w.
LPS
(n=7) over 60 min. The blood flow and the arteriolar diameters were determined using in vivo videomicroscopy at baseline, and 60 min and 120 min later. In control animals, no change in blood flow and arteriolar diameters were observed during the entire experiment. Administration of 1.5 mg/kg b.w.
LPS
reduced the blood flow to 69.5 +/- 9.0% of the baseline value at the end of the study period. This decrease in blood flow was associated with a decrease in the villus arteriolar diameters by 17.4 +/- 2.5% from the baseline values. In animals exposed to 15 mg/kg b.w.
LPS
, the decrease in villus blood flow at 60 min was 64.8 +/- 10.9% of baseline, and at 120 min 66.9 +/- 12.6% of baseline. The diameters of the villus arterioles were reduced by 11.5 +/- 2.4% and 15.1 +/- 1.7%, respectively. In the control group and in the 1.5-mg/kg
LPS
group, the mean arterial blood pressure did not change during the entire study period. In the 15-mg/kg
LPS
group, the mean arterial pressure tended to decrease after 60 min. These data suggest a reduction of villus blood flow due to vasoconstriction in the central villus arterioles during normotensive endotoxmia, which might represent the mechanism for the mucosal
ischemia
observed in critically ill patients.
...
PMID:Effect of endotoxemia on intestinal villus microcirculation in rats. 865 36
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>